Optimi Health Corp(OPTH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 4:00 PM ET (Korea 10/27 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 18.98% | Shs Outstand | 5.7M | Perf Week | -6.31% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 4.6M | Perf Month | -35.27% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 7.29% | Short Float | 0.63% | Perf Quarter | -34.45% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | 14.75% | Short Ratio | 0.77 | Perf Half Y | -58.89% |
| Sales | - | P/B | 1.44 | EPS next 5Y | - | ROA | - | Short Interest | 0.03M | Perf YTD | -54.47% |
| Book/sh | 2.17 | P/C | 1.94 | EPS past 3/5Y | 27.91% -72.14% | ROE | - | 52W High | -64.7% ($8.84) | Perf Year | -59.89% |
| Cash/sh | 1.61 | P/FCF | - | Sales past 3/5Y | 68.99% - | ROIC | - | 52W Low | 2.63% ($3.04) | Perf 3Y | -23.53% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.45% | Gross Margin | - | Volatility(W/M) | 7.88% 8.59% | Perf 5Y | -80.82% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.69 | EPS Q/Q | -842.19% | Profit Margin | - | RSI (14) | 27.22 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.73 | Sales Q/Q | 137.27% | SMA20 | -17.81% ($3.8) | Beta | 1.34 | Target Price | - |
| Payout | - | Debt/Eq | 0.29 | Earnings | 2026/8/14 | SMA50 | -29.37% ($4.42) | Rel Volume | 0.3 | Prev Close | $3.25 |
| Employees | - | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -43.14% -34.88% | SMA200 | -45.29% ($5.7) | Avg Volume(3M) | 0.04M | Price | $3.12 |
| IPO | 2026/5/20 | Option/Short | No/Yes | Trades | 160 | Volume | 11,335 | Change | -4% |
💊 Optimi Health (OPTH) is a Canada-based pharmaceutical manufacturer specializing in strict pharmaceutical-grade production of psychedelic medicines. It holds a relatively rare commercial-scale manufacturing capability for producing botanical psilocybin and MDMA legally for medical use, supplying these to regulated-permitted markets such as Australia and Canada.
Over the past 1 year, on the lower side
65% below its 1-year high.
Traded less than usual. That is 30% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -80.8%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 7.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #70 of 83 in the industry
Based on market cap of $18M.
FAQ
What kind of company is OPTH?
OPTH belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of OPTH?
The market cap of OPTH is approximately $18M, ranking 5,241 within its sector.
What is the 52-week high and low for OPTH?
OPTH has recorded a 52-week high of $8.84 and a low of $3.04.
